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RetinaObscurin is a giant structural and signaling protein that participates in the assembly and structural integrity
of striated myoﬁbrils. Previous work has examined the physical interactions between obscurin and other
cytoskeletal elements but its in vivo role in cell signaling, including the functions of its RhoGTPase Exchange
Factor (RhoGEF) domain have not been characterized. In this study, morpholino antisense oligonucleotides
were used to create an in-frame deletion of the active site of the obscurin A RhoGEF domain in order to
examine its functions in zebraﬁsh development. Cardiac myocytes in the morphant embryos lacked the
intercalated disks that were present in controls by 72 and, in the more severely affected embryos, the
contractile ﬁlaments were not organized into mature sarcomeres. Neural abnormalities included delay or
loss of retinal lamination. Rescue of the phenotype with co-injection of mini-obscurin A expression
constructs demonstrated that the observed effects were due to the loss of small GTPase activation by
obscurin A. The immature phenotype of the cardiac myocytes and the retinal neuroblasts observed in the
morphant embryos suggests that obscurin A-mediated small GTPase signaling promotes tissue-speciﬁc
cellular differentiation. This is the ﬁrst demonstration of the importance of the obscurin A-mediated RhoGEF
signaling in vertebrate organogenesis and highlights the central role of obscurin A in striated muscle and
neural development.
© 2009 Elsevier Inc. All rights reserved.Introduction
TheRhoGTPaseshave very important roles indirecting awide range
of cellular events including transcriptional regulation, cell growth and
differentiation, and cell migration (Govek et al., 2005; Hall, 2005; Jaffe
and Hall, 2005; Luo, 2000; Van Aelst and D'Souza-Schorey, 1997).
RhoGTPase activity in turn is regulated by secondary factors that either
facilitate the conversion of the GTPase from its inactive to active state
[such as G-protein coupled receptors (GPCRs) and guanine nucleotide
exchange factors (GEFs)] or inhibit GTPase activation or activity [such
as GTPase activating proteins (GAPs) and guanine nucleotide dissoci-
ation inhibitors (GDIs)] (Koh, 2007; Schmidt and Hall, 2002). Many of
these secondary factors are localized to speciﬁc intracellular locations
such that the ratio of active to inactive small GTPases can be precisely
regulated at that site. Quite commonly these secondary factors are
clustered at sites of linkage between the cellular cytoskeleton and
transmembrane adhesive complexes where they help to translate
extracellular signals into intracellular responses. Each member of thell rights reserved.Rho small GTPase family, which includes RhoA, RhoG, TC10, Rac1, and
Cdc42, activates a unique set of target proteins and signaling pathways,
eliciting distinct patterns of cellular rearrangements [reviewed in
(Wennerberg and Der, 2004)].
While much has been learned regarding the importance of
activated Rho GTPases and their downstream effectors during
development, much less is known about the factors that regulate
their activity. Recently, a novel giant structural and signaling protein,
obscurin, was identiﬁed that has a RhoGEF domain and is highly
expressed during vertebrate development (Raeker et al., 2006; Russell
et al., 2002; Young et al., 2001). Previous work has determined that
there are multiple isoforms of obscurin (Russell et al., 2002) and that
the best characterized, obscurin A, localizes to the M band and to a
lesser extent, the Z disk of striated myoﬁbrils (Borisov et al., 2004;
Kontrogianni-Konstantopoulos and Bloch, 2005; Raeker et al., 2006;
Young et al., 2001). It facilitatesmyosin integration into the sarcomere
(Borisov et al., 2004; Borisov et al., 2006; Kontrogianni-Konstanto-
poulos and Bloch, 2005; Kontrogianni-Konstantopoulos et al., 2004,
2006; Raeker et al., 2006), organizes the sarcoplasmic reticulum
(Bagnato et al., 2003; Kontrogianni-Konstantopoulos et al., 2003;
Lange et al., 2009; Raeker et al., 2006) and promotes the lateral
alignment of myoﬁbrils (Borisov et al., 2006; Raeker et al., 2006).
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a model to examine the functions of obscurin A (Raeker et al.,
2006). Due to the duplication of the zebraﬁsh genome, there are
two copies of the obscurin gene, one of which encodes for
obscurin A and related isoforms lacking the carboxy terminal
kinase domains and one of which encodes for isoforms containing
the kinase domains including the isoform obscurin B. This genetic
duplication allows for isoform-speciﬁc evaluations of obscurin
function. Given the proposed role of the obscurin A isoform in
myoﬁbril assembly, this isoform was speciﬁcally targeted for
depletion using antisense morpholinos in developing zebraﬁsh
embryos resulting in defects in skeletal muscle, cardiac, and central
nervous system development (Raeker et al., 2006). In skeletal
muscle, the myocytes were disorganized and elongated, often
extending past where the vertical myoseptum, the zebraﬁsh
equivalent of the myotendinous junction, should have been.
Cardiac manifestations included ventricular hypoplasia with re-
duced contractility and pericardial edema indicative of congestive
heart failure. More severely affected embryos demonstrated
abnormalities of central nervous system development. The mani-
festations of obscurin A depletion were likely due at least in part
to disruption of its physical interactions with other structural
elements including titin (Bang et al., 2001; Fukuzawa et al., 2008;
Young et al., 2001), myomesin (Fukuzawa et al., 2008) and ankyrin
(Bagnato et al., 2003; Kontrogianni-Konstantopoulos et al., 2003).
However, the functions of obscurin A's signaling domains and the
contribution of their loss to the observed obscurin depletion
phenotype remained to be determined.
In this study, we examined the effects of disruption of obscurin A
RhoGEF signaling on zebraﬁsh development. Intron–exon and exon–
intron targeted antisense morpholino constructs were used to induce
exon skipping, resulting in the in-frame deletion of an exon encoding
for part of the active site of the obscurin A RhoGEF domain. As noted
with obscurin A depletion, speciﬁc inhibition of the RhoGEF domain
resulted in abnormalities of central nervous system, cardiac and
skeletal muscle development. However, at the cellular level there
were signiﬁcant differences in the obscurin and obscurin RhoGEF
morphant phenotypes, suggesting important roles for obscurin
RhoGEF signaling in vertebrate neural and striated muscle develop-
ment. Speciﬁcally, inhibition of obscurin RhoGEF signaling delayed
advanced differentiation of lineage-committed but immature cardiac
myocytes and neuroblasts.
Materials and methods
Zebraﬁsh maintenance and breeding
Wild-type adult and cmlc2-EGFP transgenic zebraﬁsh were
maintained as described previously (Raeker et al., 2006).
Morpholino oligonucleotide microinjection
Two independentmorpholino antisense oligonucleotides (ObscRho-
MOs) targeting the intron–exon and exon–intron junctions of an exon
encoding for the active site of the obscurin RhoGEF domain were
designed by GENE TOOLS, LLC (Philomath, OR) [intron–exon MO, 5′-
CTGAATAATCCTGATGGATAAAAGG-3′; exon–intron MO, 5′- TTAAAC-
TACCTTCAGTAGAGCCCTG-3′]. ObscRhoMOs were co-injected at the
following concentrations: 0.1mMeach for a total of 0.2 mM (1.5 ng/nl)
or 0.2 mM each for a total of 0.4 mM (3.0 ng/nl). A standard control
(Gene Tools, Inc.) MO (5′-CCTCTTACCTCAGTTACAATTTATA-3′) was
used at 0.4 mM concentration for control injections. The obscurin A
antisensemorpholino (MO2 fromRaeker et al., 2006)was prepared and
all injections were performed as previously described. A Leica MZ16F
dissecting microscope equipped with DFC340 FX camera was used to
visualize the embryos.RNA isolation and RT-PCR
Todetermine the efﬁciency of the obscurin ARhoGEFMOs, total RNA
was isolated from uninjected and injected embryos at 48 hours post
fertilization stage (hpf) using SV Total RNA isolation System (Promega,
Madison,WI). A total of 50 ng RNAwas used in a 25-μl reaction volume
to assess mRNA expression using the iScript One-Step RT-PCR kit with
SYBR green (Bio-Rad Laboratories, Hercules, CA, USA). A 350 bp cDNA
that spanned the targeted exon was ampliﬁed by PCR (forward primer,
5′-GCCTGACCTGCGCGATTGTGA; reverse primer, 5′-GAGCGCTGGGA-
GAGGGAGGAC). To estimate the efﬁciency of exon skipping, primers
amplifying the targeted exon (forward primer, 5′-ATTATTCAGTCTCG-
GAGTTGG; reverse primer, 5′-GTAGAGCCCTGTACTTTTGAAT) and cod-
ing sequence 5′ (forward primer, 5′-AACCATTTTCCGTAACATC; reverse
primer, 5′-TTTGCCAACTCCGAGACT- GAATA) and 3′ (forward primer,
5′-TGCGGCACAGCTGGTCACTCC; reverse primer, 5′-TCCTGGCCATGG-
TTCGTCTCTGTC) of the targeted exon were used to amplify these
domains from 50 ng of total RNA from the 48 hpf control-injected and
RhoGEF MO-injected embryos. A 3-step ampliﬁcation (Denature:
95.0 °C; Anneal: 48.3 °C for targeted exon, 49.2 °C for coding sequence
5′, 56.0 °C for coding sequence 3′; Extend: 72 °C) and mRNA
quantiﬁcation was performed using the BioRad iCycler. Zebraﬁsh β-
Actin (forward primer, 5′-CCGTGACATCAAGGAGAAGCT; reverse prim-
er, 5′-TCGTGGATACCGCAAGATTCC) was used as an internal control.
mRNA rescue injection
A DNA fragment encoding zebraﬁsh Rho domain (RhoGEF/Ank)
was cloned into pcDNA-DEST53 vector and sequenced. The plasmid
was linearized with XmaI and capped mRNA was generated using the
mMESSAGE mMACHINE T7 kit (Ambion, Austin, TX, USA). 2250 pg of
transcribed RNA was co-injected along with 0.2 mM ObscRhoMOs
into 1- to 4-cell-stage embryos. ObscRhoGEF RNA in rescued embryos
at 4 and 24 hpf were detected by RT-PCR (forward primer, 5′-
CATGGCCAGCAAAGGAGAAGAA; reverse primer, 5′-GTTGTGGCGAA-
TTTTGAAGTTAGC). Expression of the RhoGEF/Ank-GFP fusion protein
(~135 Kd) was conﬁrmed by western analysis using an anti-GFP
antibody (Zymed Laboratories, Inc.) according to the manufacturer's
instructions.
Site-directed mutagenesis
Site-speciﬁc mutations were introduced into RhoGEF/Ank using
QuikChange XL Site-directed Mutagenesis (Stratagene, La Jolla, CA).
The followingmutations were created and veriﬁed by sequencing: (1)
a single base, C, was inserted near the start site of obscurin RhoGEF
sequence to shift the reading frame (Non-sense), (2) four bases of the
targeted exon of the RhoGEF domain were changed to silence
signaling activity (RhoGEF-m/Ank), (3) a stop codon (TAA) was
inserted after the PH domain (RhoGEF) (see Fig. 2G). Primers for the
QuikChange mutations are given in Table 1. All constructs were
injected at 2250 pg/embryo. Efﬁciency of rescue was assessed by an
investigator blinded to the treatment group.
Wholemount immunostaining
Paraformaldehyde ﬁxed embryos were labeled with monoclonal
anti-RhoA (Santa Cruz Biotechnology, Inc), or monoclonal anti-α-
actinin (Sigma-Aldrich Inc., #EA-53) antibodies at 1:20 dilutions. The
obscurin antibody (a generous gift of Dr. Robert Bloch, University of
Maryland) was used as previously described (Raeker et al., 2006).
TRITC-conjugated goat antimouse IgG, FITC-conjugated goat anti-
mouse IgG, and FITC-conjugated goat anti-rabbit IgG, Texas Red-
conjugated goat anti-rabbit (Jackson Immunoresearch Laboratories)
were diluted to 1:100. An Olympus FV-500 confocal microscope was
used to visualize the embryos.
Table 1
Primers for site-directed mutagenesis of ObscRhoGEF cDNA.
Frameshift F 5′-CTCGCAAATCACAGAAATGCGTATCTGCCAAGATCACAC-3′
(Non-sense) R 5′-GTGTGATCTTGGCAGATACGCATTTCTGTGATTTGCGAG-3′
Silence RhoGEF F 5′-GTGTGATCTTGGCAGATACGCATTTCTGTGATTTGCGAG-3′
(RhoGEF/
Ank-m)
R 5′-CCTTCAGTAGAGCCCTCATCGTTTGAATTCTCTCAGGTGGTCT
CTGAAG-3′
Stop after
RhoGEF
F 5′-CTTACAGCAGAGCTCGGATAACAGACTGTAAAGCTTGCC-3′
(RhoGEF) R 5′-GGCAAGCTTTACAGTCTGTTATCCGAGCTCTGCTGTAAG-3′
Fig. 1. Targeting of the obscurin A RhoGEF domain. (I) Diagram of obscurin A
demonstrating the location of the tandem immunoglobulin-like (Ig) domains, the
RhoGEF domain (Rho) and the ankyrin binding (Ank) domains. (II) Diagram of the
exons encoding the double homology (DH) domain of the RhoGEF module. A 117-bp
exon encoding for part of the GTPase activation site of the RhoGEF domain was targeted
for induced exon skipping by the injection of antisense morpholinos (black bars)
directed at the splice donor and acceptor sites for that exon. (III) Splice product 1
represents the normal splicing. The morpholinos are frequently able to block normal
splicing of the targeted exon resulting in the splice product 2. PCR primers (arrows)
from the adjacent exons were used to detect the splice products. Both products were
cloned and sequenced and the nucleotide and predicted amino acid sequences
displayed. (IV) RNA from 48 hpf embryos was isolated from obscurin A RhoGEF
(ObscRhoMO) morphant, uninjected (Uninj) control morpholino-injected (CMO)
embryos. Note that the band (b) corresponding to splice product 2 is only present in
the RNA isolated from the morphant embryos.
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Electron microscopy was performed as previously described
(Raeker et al., 2006). Brieﬂy, embryos at 72 hpf were ﬁxed with
2.5% glutaraldehyde and 2.0% paraformaldehyde and post ﬁxed in 1%
osmium tetroxide. After washing, they were stained with saturated
uranyl acetate, and embedded in Epon 812. Ultra-thin sections were
prepared and stained with saturated uranyl acetate and lead citrate.
The sections were examined with a Philips CM100 transmission
electron microscope at an accelerating voltage of 60 kV.
Embryo imaging
Digital movies were obtained on unsedated zebraﬁsh embryos at
48 and 72 hpf using a Leica MZFLIII dissecting microscope with
attached Nikon digital camera. Ten-second loops were recorded with
the embryo right side up. Ventricular diameter was measured both
along the axis of ﬂow (Maj) and perpendicular to the axis of ﬂow
(Min) at both end systole and end diastole. Ventricular volumes were
calculated assuming an ellipsoid shape [V=4/3π(Maj/2)(Min/2)2].
Ejection fractions were calculated using standard methods. Retinal
area was calculated assuming an elliptical shape of the retina. The
right eye of the embryowas imagedwith the embryo right side up and
diameters measured along its long axis and perpendicular short axis
[A=π(Maj/2)(Min/2)].
Results
Targeted deletion of the exon encoding the active site of the obscurin
RhoGEF domain
Antisense morpholinos complimentary to the intron–exon and
exon–intron boundary of a 117-bp exon encoding for part of the
obscurin RhoGEF GTPase activation site (predicted AA 5747–5785)
were injected into 1–4 cell stage zebraﬁsh embryos. RT-PCR of RNA
isolates from whole 48 hours post-fertilization (hpf) embryos
revealed that injection of both morpholinos commonly resulted in
skipping of the targeted exon. Sequencing of the RT-PCR products
conﬁrmed that the reading framewasmaintained in the alternatively-
spliced product (Fig. 1). RT-PCR demonstrated preserved expression
of the 3′ endof the alternatively spliced transcript (Supplemental Fig. 1).
There was no apparent compensatory increase in obscurin B mRNA
expression (Supplemental Fig. 1). The ratio of the expression of the
targeted RhoGEF exon toβ-actin in themorphant embryos compared to
control injected embryos was 0.47±0.14 ampliﬁcation units at 0.2 mM
morpholino dose and 0.39±0.17 units at 0.4 mM morpholino dose,
indicating average of 50–60% reduction in the expression of deleted
exon. The combinationof the twomorpholinoswasmuchmore efﬁcient
at inducing exon skipping than either morpholino alone. By band
densitometry of RT-PCR products, injection of either morpholino alone
resulted in approximately equivalent amounts of exon skipped and
correctly spliced products (Supplemental Fig. 2). Injection of both
morpholinos together resulted in an approximately 2:1 ratio of exon-
skipped to correctly spliced products. RT-PCR analysis did not detect
signiﬁcant amounts of splice products with retained introns (data notshown). If these splicing events occurred, theymay have been degraded
by non-sense mediated decay.
Rescue of the observed defects using an obscurin miniconstruct
When both morpholinos were injected together, the percentage of
72 hpf embryos with skeletal muscle, cardiac and neurologic
abnormalities was 81%, 42%, and 87% at 0.2 mM of ObscRhoMOs
(N=492) and 98%, 86%, and 97% at 0.4 mM (N=224) (Fig. 2A).
Morphant embryos were shorter and thinner with small heads and
eyes and abnormalities of cardiac structure and function.
To verify that the observed developmental defects were due to the
loss of obscurin RhoGEF activity, a miniconstruct encoding for the
RhoGEF and carboxy terminal protein interaction domains (RhoGEF/
Ank) was injected into control and ObscRhoMOs (0.2 mM) embryos.
Expression of the intact miniconstruct was conﬁrmed by RT-PCR and
western analysis (Figs. 2E, F). Injection of RhoGEF/Ank resulted a
signiﬁcant reduction in the number of affected embryos to 19% (Ni=5
injections; Ne=371). The amount of expression construct injected
Fig. 2.Obscurin A RhoGEF morphant phenotype. (A) Morphant embryos were assessed at 72 hpf and scored for head size (small head), eye morphology (small eye, poorly developed
optic cup), ear morphology (one or no otoliths), cardiac structure and function (ventricular hypoplasia or dilatation, pericardial edema) and skeletal muscle appearance (reduced tail
length and width). (B–D) Gross morphology of control (B), obscurin A RhoGEF morphant (C) (0.1 mM of each morpholino), and rescued obscurin A RhoGEF morphant embryos (D)
(0.1 mM of each morpholino+2250 pg RhoGEF/Ank expression construct). The obscurin A RhoGEF morphant embryos demonstrate a high incidence of pericardial edema (N),
moderate (^) to severe (⁎) eye hypoplasia, and smaller heads than controls. These defects were rescued ormarkedly diminished by co-injection of an obscurin A expression construct
that included the RhoGEF and ankyrin binding domains (RhoGEF/Ank). (E) RT-PCR of mRNA extracted from 4, 24 and 72 hpf embryos injected with the expression construct
demonstrating correct ampliﬁcation of the expression tag (b). (F)Western analysis (Ab: anti-EGFP) of 72 hpf whole embryo lysates demonstrating expression of a fusion protein (N)
of the expected size only in injected embryos (R) and not in control (C). (G) Percentage of obscurin A RhoGEF morphant embryos demonstrating one or more of the phenotypic
abnormalities upon co-injection with the indicated rescue construct (⁎pb0.05 compared to empty vector control). Note the high efﬁciency of rescue with the RhoGEF/Ank and the
absence of rescue with the non-sense and RhoGEF-m/Ank constructs. (H) Diagram of the amino acid sequence change introduced into the RhoGEF-m/Ank construct that replaces a
conserved KY (Lysine–Tyrosine) motif with TM (Threonine–Methionine). Underlined nucleotides were changed using site-directed mutagenesis.
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rescued the morphant phenotype without causing observable defects
when injected alone.
To conﬁrm that the rescue was due to RhoGEF activity, a single
base pair insertion to shift the reading frame of the rescue construct
was created. Co-injection of this construct (Non-sense) did not result
in signiﬁcant rescue with 70% of the embryos demonstrating
phenotypic abnormalities (Ni=2 injections; Ne=144). Injection of
a rescue construct with a translation termination codon inserted afterthe RhoGEF domain (RhoGEF) resulted in partial rescue with
abnormalities noted in 41% of the embryos (Ni=2 injections;
Ne=145). The inability of this construct to more fully rescue the
phenotype may be due to differences in mRNA or protein stability or
reduced speciﬁcity of cellular localization due to the absence of the
carboxy terminal protein interaction domains.
Failure of rescue by a construct withmutations introduced into the
GTPase activation site provided the most direct evidence of the
requirement of RhoGEF activity for the observed rescue. As noted
436 M.Ö. Raeker et al. / Developmental Biology 337 (2010) 432–443above, the targeted exon encodes for a signiﬁcant portion of the
obscurin RhoGEF GTPase activation site. Within this targeted domain,
a conserved lysine-tyrosine (KY) motif was changed to threonine–
methionine (TM) by site-directed mutagenesis (Fig. 2H). This KY
motif appears to have important structural and catalytic activities
within the GTP binding and activation domain (Liu et al., 1998). The
lysine corresponds to K-1732 of Trio GEF1 and has been demonstrated
to be required for Rac1 activation. The tyrosine (Y-1733) is a
conserved hydrophobic domain within the core of the activation
domain that appears to be an important determinant of the
architecture of the binding fold and affects binding fold access and
activation of all small GTPases (Liu et al., 1998). The conversion of the
KY motif to TM prevented phenotypic rescue with 74% of embryos
affected (Ni=2 injections; Ne=136). Injection of 2250 pg of this
construct (RhoGEF/Ank-m) alone did not result in developmental
defects.
Skeletal muscle defects
We have previously characterized the skeletal muscle phenotype
of embryos depleted of obscurin A (Raeker et al., 2006). In this study,
we compared the muscle phenotype of those embryos (ObscMO) to
the phenotype of embryos treated with morpholinos targeting the
active site of the obscurin A RhoGEF domain (ObscRhoMO) to
determine the speciﬁc functions of that domain. As in ObscMO
embryos, ObscRhoMO embryos demonstrated abnormalities of
skeletal muscle development (Figs. 3, 4) but with a distinct
morphology. One of the most consistent ﬁndings of in vivo down-
regulation or absence of obscurin (Kontrogianni-Konstantopoulos et
al., 2006; Lange et al., 2009; Raeker et al., 2006) is themispatterning of
the sarcoplasmic reticulum (SR) which may be due to interaction of
the globular carboxy terminal domain of obscurin with small ankyrins
in the sarcoplasmic reticulum (Bagnato et al., 2003; Kontrogianni-
Konstantopoulos et al., 2003). Defects in the patterning of the SR were
a prominent feature of the ObscMO skeletal muscle phenotype
(Raeker et al., 2006). The normal appearance of the SR in the skeletal
muscle of the ObscRhoMO embryos likely indicates that the carboxy
terminus of the targeted obscurin is functionally intact and suggestsFig. 3. Architecture of the myotendinous junction (MTJ). Confocal analysis using α-actin
ultrastructural analysis (D–F) to deﬁne the architecture of the MTJ was performed in control
72 hpf. In control embryos, the skeletal myocytes are aligned in parallel and the myotendin
morphant embryos vary in length and in their relationship to each other (⁎) with elongated m
to the ObscMO embryos, the obscurin A RhoGEF (ObscRhoMO) morphant embryos demons
arrangement) and normal positioning of a complete or nearly complete somite boundary (
appears electron dense and irregular, not unlike the rudimentary boundaries/MTJs noted ithat the RhoGEF signaling domain does not have a major role in SR
organization.
Another notable feature of ObscMO embryos was the elongated
skeletal myocytes that extended beyond primitive and highly
irregular vertical myoseptae, the zebraﬁsh equivalent of the myoten-
dinous junction (Raeker et al., 2006). By comparison, the vertical
myoseptae in the ObscRhoMO embryos were correctly positioned and
were usually complete, in that they extended almost the full width of
the myotome. Yet they were late to achieve a mature “chevron” shape
and were occasionally deﬁcient between the most superﬁcial
myocytes. On electron microscopic analysis, the vertical myoseptae
in the more severely affected ObscRhoMO embryos were similar in
character to those in the ObscMO embryos in that they were much
more electron-dense and less organized than those in controls (Fig. 3).
Given the abnormalities of the myotendinous junctions in both
morphant phenotypes, the structural and RhoGEF signaling properties
of obscurin A appear to cooperatively inﬂuence the reciprocal and
coordinated remodeling of the intracellular and extracellular archi-
tecture that occurs during striated muscle development.
In addition, there were notable reductions in myoﬁbril density in
the ObscRhoMO embryos. Skeletal myocytes in ObscRhoMO embryos
appeared thinner than those in the corresponding somites of control
embryos at 72 hpf with reduced myoﬁbrillar volume and increased
sarcomere-free areas of the myoplasm (Figs. 4C, F, G). The structure of
themyoﬁbrils and relationship of themyocytes to each otherwas very
similar to controls. In contrast to the skeletal myoﬁbrils of ObscMO
embryos, the myoﬁbrils in the ObscRhoMO embryos were aligned in
transverse register across the sarcoplasm with rates of misalignment
that were comparable to controls (b5%). The higher order structure of
the skeletal muscle was also similar to controls with ObscRhoMO
myoﬁbrils and myocytes demonstrating a more consistent parallel
arrangement compared to the “twisting” of myoﬁbrils and myocytes
noted in ObscMO skeletal muscle (Figs. 4B, E).
Compared to the dramatic alteration of skeletal muscle architec-
ture in the ObscMO embryos, the abnormalities of sarcomere
structure in the ObscRhoMO embryos was much more subtle and
could only be detected by electron microscopic analysis. For instance,
Z disks in control and ObscMO embryos rapidly achieved a “stitched”in (a Z disk component) immunolabeling (A–C) to assess myoﬁbril morphology and
(A, D), obscurin A morphant (B, E) and obscurin A RhoGEF morphant (C, F) embryos at
ous junctions are well deﬁned (A, D: N). The skeletal myocytes in obscurin A (ObscMO)
yocytes extending past very rudimentary somite boundaries (B, E: N). When compared
trate a more consistent relationship between adjacent myocyte (more uniform parallel
C,F: N). However, the boundary is not sharply deﬁned as in control embryos and often
n ObscMO embryos. Scale bars are 20 μm (A–C) and 2 μm (D–F).
Fig. 4. Skeletal muscle phenotype in obscurin A RhoGEF morphant embryos at 72 hpf. Ultrastructural analysis was performed at 72 hpf on control, obscurin A (ObscMO) and obscurin
A RhoGEF (ObscRhoMO) morphant embryos. In control embryos, the myoﬁbrils are aligned in register across the sarcoplasm (A) with well deﬁned M bands and ﬁnely “stitched” Z
disks (D). In the obscurin morphant embryos (B) there is marked disturbance of myoﬁbril organization with areas of misalignment of the M bands of adjacent myoﬁbrils (E: ^). By
comparison, the obscurin A RhoGEF morphants display myoﬁbril organization (C) similar to control embryos but reduced myoﬁbrillar content with more sarcoplasm devoid of
myoﬁbrils and more rounded nuclei (C, G: ^). There were also mild sarcomeric abnormalities including, infrequently, an indistinct appearance of the Z disk and absence of the M
band (F: ⁎) which could occur even withinmyoﬁbrils demonstrating mature Z disks andM bands (F: ^). Note that in skeletal myocytes stained with DAPI, the nuclei in the obscurin A
RhoGEF morphants (RhoMO) are closer together and more rounded (G) than in controls (H) consistent with reduced myoﬁbril volume. Scale bars 2 μm (A–C), 0.5 μm (D–F) and
10 μm (G, H).
437M.Ö. Raeker et al. / Developmental Biology 337 (2010) 432–443or interdigitated appearance shortly after their assembly. In contrast,
Z disks of newly formed sarcomeres added at the terminal ends of the
myoﬁbril and formed by lateral addition to existing myoﬁbrils often
displayed a “fuzzy” appearance in the ObscRhoMO morphants
(Fig. 4F). This appeared to be the result of a delay in maturation as
opposed to a permanent structural abnormality as the Z disks of
mature myoﬁbrils were indistinguishable from those in controls.
The other subtle sarcomeric abnormality noted was an inconsis-
tent appearance of the M bands. In the vast majority of skeletal
myoﬁbrils in the ObscRhoMO embryos, well-formedM bands could be
identiﬁed. However, unlike control and ObscMO embryos,
ObscRhoMO embryos displayed a small number of skeletal myoﬁbrils
that lacked well-deﬁned M bands on ultrastructural analysis at 72 hpf
(Fig. 5). Absent or poorly deﬁned M bands most commonly occurred
in newly formed skeletal myoﬁbrils (Fig. 4F), but were also noted in
more mature myoﬁbrils (Fig. 5C), indicating that the obscurin A
RhoGEF domain may participate in the recruitment and stabilization
of protein complexes within the M band. The absence of the M band
was reminiscent of Caenorhabditis elegans Unc-89 mutants that lack a
well formed M band (Benian et al., 1996).Fig. 5. Absence of consistent M bands in obscurin A RhoGEF skeletal muscle at 72 hpf. Contro
by 72 hpf. Obscurin A morphant embryos (B), although they display marked abnormaliti
contrast, skeletal myoﬁbrils in obscurin A RhoGEF morphant embryos (C) demonstrated occa
extrajunctional SR in the ObscMO embryo is markedly disorganized (B: arrow), but is mucCardiac defects
The cardiac defects noted in the RhoGEF morphant embryos were
grossly similar to those previously noted in the obscurin A morphant
embryos (Raeker et al., 2006). Cardiac abnormalities ranged frommild
cardiac dilatation to severe cardiac hypoplasia (Fig. 6). Cardiac
hypoplasia often resulted in a stretched appearance to the heart as
the rest of the embryo continued to grow and develop. In the more
severely affected embryos (Figs. 6E, F), there was markedly reduced
cardiac output. Since the diminished ﬂow through the heart can affect
its function, the functional properties of the morphant hearts were
assessed in the more mildly affected embryos (Figs. 6B–D). Even in
embryos with end-diastolic volumes similar to controls (Fig. 6H),
there were noted to be lower heart rates and reduced ejection
fractions at 48 and 72 hours (Figs. 6G, I). The reduced calculated
stroke volume (Fig. 6J) and lower heart rates would predict a decrease
in cardiac output that may have contributed to the observed
pericardial edema (Figs. 6D–F).
Ultrastructural analysis was performed at 72 hpf using transmis-
sion electron microscopy (Fig. 7). As with the skeletal myocytes,l embryos (A) consistently demonstrate well-formed M bands (N) in skeletal myoﬁbrils
es in myoﬁbrillar architecture, also consistently demonstrate mature M bands (N). In
sional absence of M bands (⁎) in otherwise mature-appearing myoﬁbrils. Note that the
h more normal appearing in the ObscRhoMO embryos (C: arrow).
Fig. 6.Obscurin A RhoGEF signaling is required for normal cardiac development. Cmlc2-EGFP transgenic zebraﬁsh embryos injected with obscurin A RhoGEFmorpholinos (B–F) were
compared to control-injected transgenic embryos (A) at 72 hpf. Morphant embryos demonstrated a spectrum of cardiac abnormalities ranging from reduced cardiac function with
cardiac dilatation andmild pericardial edema (B–D) tomild (E) or severe (F) ventricular hypoplasia and pericardial edema (b). (G–J) Cardiac functional assessments were performed
inmorphant (black bars) and control embryos (white bars) at 48 and 72 hpf. In themoremildly affected embryos withmild ventricular hypoplasia as determined by comparable end
diastolic volume measurements relative to controls (I), there were signiﬁcant reductions in heart rate (G), ejection fraction (H) and stroke volume (J) at 48 and 72 hpf compared to
controls (⁎t-test; pb0.05).
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within each myocyte suggestive of a reduction in the number of
mature contractile units/cell (Figs. 7C, D). There also appeared to be
signiﬁcant abnormalities in the formation of cell–cell contacts. Unlike
cardiac myocytes in control embryos that had formed mature
intercalated disks with identiﬁable gap and adherens junctions by
72 hpf (Figs. 7A, B), cardiac myocytes in ObscRhoGEF embryos had
very indistinct cell–cell contacts (Figs. 7C, D) with no adherens
junctions. This is again consistent with close structural and signaling
interactions between obscurin A and transmembrane cell adhesion
complexes.
Although reduced in number, the morphology of the mature
cardiac myoﬁbrils that did form was not appreciably different in
ObscRhoMO embryos than in controls (Figs. 7E, F). The lattice of
myosin thick ﬁlaments was well organized and evenly spaced in
contrast to what has previously been noted in skeletal myotubes
depleted of the full obscurin A (Kontrogianni-Konstantopoulos et al.,2006; Raeker et al., 2006). This suggests that the arrangement of the
thick ﬁlaments is more dependent upon the structural properties of
obscurin A than the signaling properties of its RhoGEF domain.
The constellation of abnormalities noted in the obscurin A
RhoGEF-depleted cardiomyocytes would suggest that they were less
differentiated than cardiomyocytes from control embryos of the same
developmental stage (as determined by hpf and somite number). The
absence of mature cell–cell contacts and small cells with sparse
myoﬁbrils is consistentwith a less differentiated state.Whether or not
cardiac myocytes depleted of obscurin RhoGEF activity might
eventually fully differentiate is more difﬁcult to determine as the
marked decrease or absence of blood ﬂow due to the ventricular
hypoplasia often resulted in ventricular chamber collapse as has been
noted in response to mechanical interruption of ﬂow during cardiac
development (Hove et al., 2003). The capacity for other signaling
mechanisms to eventually compensate for the loss of obscurin
RhoGEF signaling may account for the difference in phenotype
Fig. 7. Ultrastructural analysis of cardiac myocytes at 72 hpf. (A) Cardiac myocytes in control embryos have formed intercalated disks (^) and ﬁlled the sarcoplasm with mature
myoﬁbrils. (B) Higher magniﬁcation of an intercalated disk (ID) from a control embryo demonstrates adherens (N) and gap (^) junctions. (C, D) In contrast, cardiac myocytes from
mildly affected obscurin A RhoGEF morphant embryos have reduced myoﬁbrillar content [compare the nuclear (N) area to the myoﬁbrillar area within each myocyte] and very
poorly deﬁned regions of cell–cell (^) contact with no identiﬁable IDs. Examples of recent nuclear division (N+) were more frequent in the obscurin RhoGEF morphant embryos.
(E, F) In more severely affected embryos, cardiac myocytes appear markedly abnormal with loosely arranged contractile ﬁlaments (F: ⁎). (G, H) The mature cardiac myoﬁbrils that
did form in the obscurin A RhoGEF morphant embryos were not signiﬁcantly different than control with a normal appearing lattice of thick ﬁlaments on cross-section (G) and
laterally aligned Z disks and M bands on longitudinal section (H). Scale bars are 4 μm (A–C), 2 μm (D, E), 1 μm (F) and 0.5 μm (G, H).
Fig. 8. Small eye phenotype of obscurin A RhoGEF morphant embryos. Compared to
control (white bars) embryos the retinal disks of morphant embryos (black bars)
exhibit slowed growth. The growth discrepancy reaches statistical signiﬁcance by
72 hpf (⁎t-test: pb0.05).
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obscurin null mouse (Lange et al., 2009).
Neural development
In addition to the above-noted delays in striated muscle develop-
ment, obscurin A RhoGEF morphant embryos were noted to have
abnormalities of neural development. In control embryos, obscurin A
mRNA (Raeker et al., 2006) and protein expression (Figs. 9A, E) was
noted in thedevelopingbrain and retina ina pattern thatmirroredRhoA
expression (Fig. 9B). Due to its well-characterized pattern of differen-
tiation in zebraﬁsh embryos, the developing retina was examined as
model of the role of obscurin A RhoGEF signaling in the brain.
Obscurin was expressed in all layers of the developing retina but
was most abundant in the inner plexiform layer and at the apical and
basal surfaces of the outer nuclear layer. The inner plexiform layer is
ﬁlled with axons and it is likely that obscurin and RhoA signaling have
important roles in extending axons. Depletion of the obscurin A
RhoGEF signaling domain resulted in morphant embryos with small,
poorly developed eyes (Fig. 8) with persistent cellularity of the lens,
hypoplasia of the optic nerve, and poorly deﬁned layers within the
retina. In the more severely affected embryos, the cells were
elongated and relatively uniform in appearance, lacking any of the
identiﬁable layers normally present at this stage of development
(Figs. 9D, H). Of note, this was not associated with a global delay in
development as the embryos had the same number of somites as the
control embryos and only moderate abnormalities of skeletal muscle
development as noted above.Retinal development is dependant upon the interaction of
secreted and cell-contact signals directing complex morphogenetic
changes in retinal neuroblasts that lead to their lamination
(layering) and differentiation (Galli-Resta et al., 2008; Hitchcock
and Raymond, 2004; Neumann and Nuesslein-Volhard, 2000). In
even the most severely affected ObscRhoMO embryos, retinal
development had advanced beyond the invagination of the optic
cup and the development of two identiﬁable cell layers, the retinal
pigment epithelium of the outer retina and the inner retinal
neuroepithelium. However, in the more severely affected morphant
embryos (4 out of 12 examined by EM or immunohistochemical
analysis), there was no signiﬁcant differentiation beyond that point
by 72 hpf with cells in the retinal neuroepithelium remaining
Fig. 9. Eye phenotype of obscurin A RhoGEF embryos. Control (A, B, E) and obscurin RhoGEF (C, D) morphant embryos were immunolabeled for Obscurin (A,E) or RhoA (B–D) at
72 hpf. In the control embryo, distinct retinal layers are noted [ganglion cell layer (GCL), inner plexiform layer (IPL), inner nuclear layer (INL), outer plexiform layer (OPL), and outer
nuclear layer (ONL)]. Obscurin is expressed in each of the layers, usually at the cell periphery with the greatest abundance in the axon-rich IPL (A) and at the apical and basal aspects
of the ONL (E) in a distribution similar to RhoA (A, B). In the mildly affected obscurin A RhoGEF morphant embryos (C), rudimentary GCL, IPL, INL, OPL, and ONL are noted while the
more severely affected embryos do not develop identiﬁable layers (D). On ultrastructural analysis, there is signiﬁcant pigment deposition and a well developed photoreceptor layer
(^) in the retina of a control embryo (F) while even a mildly affected morphant embryo (G) has very little pigmentation and no identiﬁable photoreceptors. A more severely affected
embryo (H) lacks even rudimentary layers and the cells remain elongated and poorly differentiated. Scale bars are 20 μm (A–D) and 10 μm (E–H).
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(Figs. 9D, H). In contrast, control embryos at that stage of
development had formed easily identiﬁable ganglion cell (GCL),
inner and outer plexiform (IPL and OPL), and inner and outer
nuclear (INL and ONL) layers (Figs. 9B, F).
Previous studies have demonstrated that retinal neuroblasts are
anchored apically via cell–extracellular matrix interactions to the
inner limiting membrane and at the basal surface that apposes the
pigmented epithelium are linked to each other by a network of
adherens junctions (cell–cell contacts) (Galli-Resta et al., 2008). This
polarity is essential for the correct orientation of future cell divisions
that will lead to retinal layering. In the more mildly affected embryos,
layering does proceed in a normal but delayed fashion, with the
appearance of a ganglion cell layer, inner and outer plexiform layers
and inner and outer nuclear layers (Figs. 9C, G). The inner nuclear
layer further divides into two sublayers, potentially representing
amacrine and bipolar/horizontal cell precursors. In the ObscRhoMO
embryos, none of the layers are highly differentiated but they do
appear to all be present and to be correctly positioned, suggesting that
obscurin A RhoGEF signaling primarily determines the rate of retinal
differentiation rather than affecting cell fate determination or the
organization of the layers. Since obscurin A is expressed in the
developing zebraﬁsh eye (Raeker et al., 2006) and retinal develop-
ment is not entirely dependent on brain development after the
development of an optic cup (with formation of the retinal pigment
epithelium and the retinal neuroepithelium), these abnormalities
appear to be consistent with a primary delay in the progressive
differentiation of the primitive retinal layers due to impaired obscurin
RhoGEF-mediated small GTPase signaling.
Discussion
This is the ﬁrst study to demonstrate a role for the obscurin A
RhoGEF domain in the signaling processes that direct organogenesis
in the brain, skeletal muscle and heart. Much of the work on obscurin
to date has focused on its role in the assembly, organization and
structural support of striated myoﬁbrils (Bagnato et al., 2003; Bang etal., 2001; Borisov et al., 2004, 2003, 2006; Kontrogianni-Konstanto-
poulos and Bloch, 2005; Kontrogianni-Konstantopoulos et al., 2004,
2006, 2003; Raeker et al., 2006). In these studies it was determined
that obscurin promotes the stable integration of myosin ﬁlaments
into the myoﬁbril (Borisov et al., 2006; Kontrogianni-Konstantopou-
los et al., 2006) and that it may act as a primary scaffold for the thick
ﬁlament array (Borisov et al., 2004, 2006) in part through
interactions with M band titin and myomesin (Fukuzawa et al.,
2008). Therefore, it is not surprising that inhibition of obscurin A-
mediated RhoGTPase activation reduced the assembly of new
myoﬁbrils. Cardiac myocytes in the most severely affected embryos
were deﬁcient in mature sarcomeric structures with contractile
ﬁlaments forming disorganized tangles within the sarcoplasm. Even
the more mildly affected embryos demonstrated reduced myoﬁbril-
lar content in both the heart and skeletal muscle. In the myoﬁbrils
that did form, the architecture of the sarcomeres was well preserved.
The most notable effects on sarcomere structure were the occasional
absence of a well-formed M band and the indistinct appearance to
the Z disk in newly-formed myoﬁbrils. The absence of a well-formed
M band is a common feature of C. elegans embryos with mutations of
Unc-89 (Benian et al., 1996) and our study suggests that the obscurin
RhoGEF domain may participate in the scaffolding and organization
of the M band. The targeting of obscurin RhoGEF activity also had
subtle effects on Z disk morphology in skeletal muscle. This may be
due to the effect of obscurin RhoGEF signaling on the integration of
the Z band region of titin. In a recent study, overexpression of the
obscurin RhoGEF domain interfered with Z band titin incorporation
(Bowman et al., 2008). Certainly the delay in maturation of the Z disk
or the decreased number of myoﬁbrils per cell may reﬂect
irregularities in Z band titin incorporation. That those abnormalities
weren't more severe or more persistent may be due to partial
phenotypic rescue by endogenous obscurin B RhoGEF activity, which
is not affected by our obscurin A RhoGEF targeting, residual RhoGEF
activity of obscurin A due to the subset of transcripts not targeted by
the morpholinos or compensation by other RhoGEF proteins. It is also
possible that the effects of obscurin RhoGEF on titin incorporation
are not related to the signaling properties of the GEF domain but
441M.Ö. Raeker et al. / Developmental Biology 337 (2010) 432–443physical properties that may not have been dramatically affected by
the 39 amino acid deletion.
Furthermore, as with our previous in vivo studies (Raeker et al.,
2006), the current studies suggest that obscurin A also has
important extrasarcomeric functions within striated muscle. In our
prior work, we demonstrated that obscurin A participates in the
alignment of myoﬁbrils in register across the sarcoplasm and in the
positioning of other cellular domains with respect to the contractile
apparatus. Depletion of obscurin A during development resulted in
the alteration of the internal cellular structure of the myocyte and
had secondary effects on the interactions between adjacent
myocytes and between myocytes and the extracellular matrix (see
Figs. 3B, E and Figs. 4B, E). The proposed relationship of obscurin
with the submembrane cytoskeleton and transmembrane com-
plexes was supported by the recent ﬁnding that obscurin localizes
to the subsarcolemmal region of the neuromuscular junction (NMJ)
in skeletal muscle ﬁbers (Carlsson et al., 2008). The post-synaptic
endplate of the NMJ is a region rich in nuclei, mitochondria,
adhesive contacts and cytoskeletal elements. It overlies but is not
closely associated with the myoﬁbril. Therefore, obscurin's abundant
localization to the motor end plate supports its characterization as a
cytoskeletal ﬁlament that interacts with the submembrane cyto-
skeleton to regulate cellular architecture and stabilize interactions
between the cell and the extracellular environment, including
surrounding cells and the ECM. A similarly close relationship
between the invertebrate orthologue of obscurin, Unc-89, and
transmembrane adhesive complexes has been proposed. Unc-89
has been noted to be recruited to integrin-based adherens junction
complexes by actopaxin/pat-6 (Lin et al., 2003) and integrin-linked
kinase (ILK)/pat-4 (Mackinnon et al., 2002) and the interaction of
Unc-89 with these complexes likely promotes the assembly of the
thick ﬁlaments into organized arrays (Benian et al., 1996).
While obscurin A, like Unc-89, has been primarily considered a
striated muscle protein, it is clear from the current study that it also
has important functions in the developing central nervous system
where it may serve a similar role in regulating reciprocal interactions
between the intracellular and extracellular environments. We have
previously noted that, prior to its expression in striated muscle,
obscurin is expressed in the developing brain and neural tube of
zebraﬁsh and mouse (Raeker et al., 2006). As development proceeds,
its expression in the central nervous system is downregulated,
eventually persisting at signiﬁcant levels only in specialized regions
including the caudate nucleus, cerebellum and hippocampus (Nagase
et al., 2000), sites of suspected ongoing neurogenesis in the adult
brain (Kuhn et al., 1996; Lois and Alvarez-Buylla, 1993; Luskin, 1993;
Ponti et al., 2008).
Given the high level of expression and the important roles of small
GTPase signaling in neural development [reviewed in (Govek et al.,
2005)], it is not entirely unexpected that targeting the obscurin A
RhoGEF domain would have an effect on the developing brain. Other
RhoGEFs that have been demonstrated to have important roles in
neural development include Kalirin and Trio, the vertebrate ortholo-
gues of Unc-73/Drosophila trio (Steven et al., 1998). Both trio and
kalirin have two RhoGEF domains and a single serine-threonine
kinase domain at their carboxy termini that are highly homologous to
that of obscurin (Russell et al., 2002) suggesting a close evolutionary
relationship between obscurin and trio/kalirin (Russell et al., 2002).
Both trio and kalirin have been proposed to have important roles in
neural and skeletal muscle development (Hansel et al., 2001; O'Brien
et al., 2000), and to participate in the cytoskeletal adaptations that
promote neuroblast migration and axon extension (Bateman and Van
Vactor, 2001; Penzes et al., 2001). Cellular depletion of trio in
developing myotubes commonly results in myotube collapse pre-
sumably due to impaired cell–cell and/or cell–matrix interactions
(Dalkilic et al., 2006; O'Brien et al., 2000). In support of this assertion,
trio has been demonstrated to regulate focal adhesion dynamics,potentially through interactions with focal adhesion kinase (FAK)
(Medley et al., 2003).
The small GTPases activated by obscurin A were not directly
examined in this study. Recent studies have identiﬁed RhoA (Ford-
Speelman et al., 2009) and TC10, also known as RhoQ (Coisy-Quivy et
al., 2009), as targets for activation by the obscurin RhoGEF domain.
Demonstration that the RhoGEF domain of Unc-89, the invertebrate
orthologue of obscurin, is capable of activating Rho1, the invertebrate
orthologue of RhoA (Qadota et al., 2008) further supports RhoA as a
target of obscurin-mediated signaling. We did note co-localization of
RhoA with obscurin in the retina and muscle (Supplemental Fig. 3)
and certainly many of the developmental defects that were observed
in this study would be consistent with the loss of RhoA activation. In
addition to its role in neural development, RhoA has been noted to
promote skeletal muscle differentiation and muscle hypertrophy
through serum response factor (SRF)-mediated activation of a
myogenic program (Hill et al., 1995; Wei et al., 1998). Reduced
activation of this myogenic program could account for the relative
atrophy of the skeletal muscle and the immature appearance of the
cardiac myocytes in the developing heart (Li et al., 2005; Parmacek,
2007).
It is important to compare the ﬁndings in our zebraﬁsh models to
those of the obscurin null mouse (Lange et al., 2009). Somewhat
surprisingly, the obscurin null mouse demonstrated only a mild
myopathy as noted by an increasednumber of regeneratingmyoﬁbrils.
Based on theﬁndings in theobscurinAmorphant embryos (Raeker et al.,
2006) and the current study, we would predict that the myopathy may
be due to abnormalities of calcium handling related to disturbance of SR
architecture or due to myotube detachment related to impaired cell–
matrix interactions. The lack of a more severe phenotype in the null
mouse may be due to compensatory processes that may be species-
dependent. OBSL1 (Fukuzawa et al., 2008; Geisler et al., 2007) may be
able to compensate for some of the structural properties of obscurin
while trio/kalirinmaybe able to compensate for loss of obscurin RhoGEF
signaling. The ability of compensatory mechanisms to mask protein
functions in a species-speciﬁc manner is evident from muscular
dystrophy models in which loss of dystrophin in the zebraﬁsh (Bassett
and Currie, 2004; Bassett et al., 2003) more closely approximates the
human condition than does the null mouse model (Bulﬁeld et al., 1984;
Durbeej and Campbell, 2002). For obscurin, it is likely that both models
will be important for understanding the unique and shared functions of
obscurin and closely related structural and signaling molecules such as
OBSL1 and trio.
Model of obscurin A function
Based on the above studies and previous characterization of
obscurin A, it appears that, in addition to its role in thick ﬁlament
assembly and organization, obscurin A has important functions in the
structural integration of the sarcomere with the extrasarcomeric
cytoskeleton, and with speciﬁc domains of the sarcoplasmic reticu-
lum. As such, it is well situated to participate in pathways that
translate mechanical signals into intracellular adaptive responses
through the activation of small GTPases. Based on this study, obscurin
A RhoGEF-mediated small GTPase activation does appear to be an
important tissue-speciﬁc link between the transmembrane signaling
pathways that initiate cellular differentiation and the morphologic
changes that accompany differentiation. In the setting of reduced
obscurin A RhoGEF signaling, the cells appear poised for differenti-
ation but slow to proceed due to the alteration in small GTPase
activation.
Summary
This is the ﬁrst demonstration of the important role of obscurin A
RhoGEF activity in heart, skeletal muscle and neural development. The
442 M.Ö. Raeker et al. / Developmental Biology 337 (2010) 432–443immature phenotype of the cardiac myocytes and the retinal
neuroblasts observed in response to molecular targeting of this
domain suggests that obscurin A-mediated small GTPase signaling
functions as a tissue-speciﬁc molecular switch that promotes
advanced cellular differentiation. In heart and skeletal muscle, it
may be capable of activating a myogenic program that promotes the
maturation of cell–cell and cell–matrix contacts and the assembly of
new myoﬁbrils.
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